KIM185, a monoclonal antibody to CD18 which induces a change in the conformation of CD18 and promotes both LFA-1- and CR3-dependent adhesion.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 7690325)

Published in Eur J Immunol on September 01, 1993

Authors

D Andrew1, A Shock, E Ball, S Ortlepp, J Bell, M Robinson

Author Affiliations

1: Department of Inflammation Biology, Celltech Ltd., Slough, GB.

Articles citing this

Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60

The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol (2000) 2.72

NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci U S A (2000) 1.75

Dual role of the actin cytoskeleton in regulating cell adhesion mediated by the integrin lymphocyte function-associated molecule-1. Mol Biol Cell (1997) 1.54

Observing force-regulated conformational changes and ligand dissociation from a single integrin on cells. J Cell Biol (2012) 1.33

Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction. Clin Diagn Lab Immunol (2002) 1.31

A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-1. J Clin Invest (1999) 1.29

Cytoplasmic tails of beta 1, beta 2, and beta 7 integrins differentially regulate LFA-1 function in K562 cells. Mol Biol Cell (1997) 1.19

Lateral mobility of individual integrin nanoclusters orchestrates the onset for leukocyte adhesion. Proc Natl Acad Sci U S A (2012) 1.15

Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3. J Cell Biol (1994) 1.12

Folding of the conserved domain but not of flanking regions in the integrin beta2 subunit requires association with the alpha subunit. Proc Natl Acad Sci U S A (1997) 1.07

Definition of EGF-like, closely interacting modules that bear activation epitopes in integrin beta subunits. Proc Natl Acad Sci U S A (2001) 1.01

Effects of I domain deletion on the function of the beta2 integrin lymphocyte function-associated antigen-1. Mol Biol Cell (2000) 0.98

CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions. Mol Biol Cell (2013) 0.97

Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators. Br J Pharmacol (1995) 0.96

Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes. Immunology (2003) 0.96

Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin. J Biol Chem (2007) 0.95

Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea-pig skin. Br J Pharmacol (1994) 0.92

A novel point mutation in CD18 causing the expression of dysfunctional CD11/CD18 leucocyte integrins in a patient with leucocyte adhesion deficiency (LAD). Clin Exp Immunol (2000) 0.91

Na+/H+ exchange activity during phagocytosis in human neutrophils: role of Fcgamma receptors and tyrosine kinases. J Cell Biol (1996) 0.88

A role of kindlin-3 in integrin αMβ2 outside-in signaling and the Syk-Vav1-Rac1/Cdc42 signaling axis. PLoS One (2013) 0.85

Adhesive dynamics simulation of G-protein-mediated chemokine-activated neutrophil adhesion. Biophys J (2009) 0.85

Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury. Biochim Biophys Acta (2013) 0.83

Involvement of Fcgamma receptors and beta2 integrins in neutrophil activation by anti-proteinase-3 or anti-myeloperoxidase antibodies. Clin Exp Immunol (2003) 0.80

Critical amino acids in the lymphocyte function-associated antigen-1 I domain mediate intercellular adhesion molecule 3 binding and immune function. J Exp Med (1996) 0.78

Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3. J Biol Chem (2016) 0.75

alpha(4) integrin-dependent eosinophil recruitment in allergic but not non-allergic inflammation. Br J Pharmacol (2001) 0.75

Dynamin2 controls Rap1 activation and integrin clustering in human T lymphocyte adhesion. PLoS One (2017) 0.75

Articles by these authors

(truncated to the top 100)

Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science (2001) 24.48

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 9.59

Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet (2005) 7.25

Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80

Codon usage can affect efficiency of translation of genes in Escherichia coli. Nucleic Acids Res (1984) 4.51

Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med (2001) 4.27

Is your 'double-blind' design truly double-blind? Br J Psychiatry (1989) 3.98

Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol (2004) 3.80

Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell (1998) 3.80

The reliability of Cancer Registry records. Br J Cancer (1993) 3.70

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology (1987) 3.35

HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15

Coping with winter bed crises. New surveillance systems might help. BMJ (1999) 2.78

The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med (1999) 2.76

Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis (1991) 2.66

Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study. Am J Gastroenterol (1991) 2.54

The effect of feeding with a tryptophan-free amino acid mixture on rat-liver polysomes and ribosomal ribonucleic acid. Biochem J (1966) 2.53

A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50

Empirical research on informed consent. An annotated bibliography. Hastings Cent Rep (1999) 2.45

The human transmissible spongiform encephalopathies (TSEs): implications for dental practitioners. Br Dent J (2000) 2.41

Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet (2008) 2.37

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry (2001) 2.34

Methadone dosage and retention of patients in maintenance treatment. Med J Aust (1991) 2.31

Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med (2001) 2.30

THE RENAL CLEARANCE OF PENICILLINS F, G, K, AND X IN RABBITS AND MAN. J Clin Invest (1947) 2.29

Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet (1999) 2.27

Leukemia following Hodgkin's disease. N Engl J Med (1990) 2.25

A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol (1995) 2.20

The Leeds University Maternity Audit Project. Int J Qual Health Care (2002) 2.19

Linkage of COL1A2 collagen gene to cystic fibrosis, and its clinical implications. Lancet (1985) 2.14

RTX toxins recognize a beta2 integrin on the surface of human target cells. J Biol Chem (1997) 2.12

Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study. Br J Clin Pract Suppl (1994) 2.09

Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res (1984) 2.07

Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol (1988) 2.06

Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int (2000) 2.06

Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. J Immunol (1992) 2.05

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Gene Ther (2003) 2.05

Intensive treatment of multiple myeloma and criteria for complete remission. Lancet (1989) 2.04

Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04

Doctors detected self-administering opioids in New South Wales, 1985-1994: characteristics and outcomes. Med J Aust (1998) 2.04

Contributions of community involvement to organizational-level empowerment: the federal Healthy Start experience. Health Educ Behav (2001) 2.03

'But they don't see the whole child...' health visitors may not welcome systematic reviews of child health surveillance. Br J Gen Pract (1999) 2.02

Single pass sequencing and physical and genetic mapping of human brain cDNAs. Nat Genet (1992) 2.01

Disease in children infected with HIV in Abidjan, Côte d'Ivoire. BMJ (1996) 1.92

Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial. Cancer Chemother Pharmacol (1986) 1.87

Homograft replacement of the aortic valve. Immediate results and follow-up. Lancet (1968) 1.85

Non-invasive evaluation of liver cirrhosis using ultrasound. Clin Radiol (2009) 1.82

Effect of intravenous streptokinase on early mortality in patients with suspected acute myocardial infarction. A meta-analysis by anatomic location of infarction . Ann Intern Med (1990) 1.82

Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. J Virol (1995) 1.81

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis (1996) 1.79

Leukemia following chemotherapy for ovarian cancer. N Engl J Med (1990) 1.76

Completeness of cancer registration: a new method for routine use. Br J Cancer (2000) 1.75

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74

Dental caries and microbial acid production in twins. Caries Res (2005) 1.73

Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med (1998) 1.71

A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project. J Am Coll Cardiol (1999) 1.71

Registrar operating experience over a 15-year period: more, less or more or less the same? Surgeon (2004) 1.71

Detection of secondary predation by PCR analyses of the gut contents of invertebrate generalist predators. Mol Ecol (2005) 1.71

Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol (1996) 1.70

Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res (1999) 1.69

Serum immunoreactive trypsin in cystic fibrosis. Thorax (1981) 1.68

Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer (1993) 1.67

Treatment of intracranial aneurysms with preservation of the parent vessel: results of percutaneous balloon embolization in 84 patients. AJNR Am J Neuroradiol (1990) 1.65

Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol (2000) 1.64

Relationships between B-lineage lymphocytes and stromal cells in long-term bone marrow cultures. Eur J Immunol (1987) 1.64

Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet (2000) 1.62

High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis (2000) 1.61

The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet (1999) 1.61

Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. Am J Gastroenterol (1993) 1.61

Surgical management of iris defects with prosthetic iris devices. Eye (Lond) (2005) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res (1992) 1.57

Biochemical characterization of the 94- and 78-kilodalton glucose-regulated proteins in hamster fibroblasts. J Biol Chem (1984) 1.54

Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J Pathol (1987) 1.54

Autopsy consent practice at US teaching hospitals: results of a national survey. Arch Intern Med (2000) 1.54

Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol (2000) 1.53

Sensitivity and selectivity in protein similarity searches: a comparison of Smith-Waterman in hardware to BLAST and FASTA. Genomics (1996) 1.53

Hydrated silicate minerals on Mars observed by the Mars Reconnaissance Orbiter CRISM instrument. Nature (2008) 1.52

Glycemic control and implant stabilization in type 2 diabetes mellitus. J Dent Res (2009) 1.50

Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol (1998) 1.50

Pseudo-Fleischer ring after hyperopic laser in situ keratomileusis. J Cataract Refract Surg (1999) 1.48

Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma. Lancet (1983) 1.47

DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry (2008) 1.47

Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol (1997) 1.46

The medium chain triglyceride diet and intractable epilepsy. Arch Dis Child (1986) 1.45

Effect of cyanide in dark and light on the membrane potential and the ATP level of young and mature green tissues of higher plants. Plant Physiol (1983) 1.45

Neurobiology of depression: an integrated view of key findings. Int J Clin Pract (2007) 1.44

Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med (1994) 1.44

Differences in patterns of care of prostate cancer, New South Wales, 1991. Aust N Z J Surg (1996) 1.43

Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene (1996) 1.42

Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferon. Gynecol Oncol (1992) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Density of lymphocytic infiltration of primary breast cancer does not affect short-term disease-free interval or survival. J R Coll Surg Edinb (1990) 1.41

Molecular genetics of Drosophila alpha-actinin: mutant alleles disrupt Z disc integrity and muscle insertions. J Cell Biol (1990) 1.41

An evaluation of a "best practices" musculoskeletal injury prevention program in nursing homes. Inj Prev (2004) 1.41

The landing of the NEAR-Shoemaker spacecraft on asteroid 433 Eros. Nature (2001) 1.41

Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects. Aliment Pharmacol Ther (2004) 1.41

The preservation of charitable health care assets. Health Aff (Millwood) (1997) 1.41

CT evaluation for 'quiescent' herniation following closure of diverting loop ileostomy. Colorectal Dis (2012) 1.41

Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group. Am J Gastroenterol (1993) 1.40